Shawn Kubli

Company: Treadwell Therapeutics

Job title: Head, Cell Therapy Division

Seminars:

Mediating Successful Discovery of ‘Good’ TCRs that will Successfully Translate into the Clinic 3:30 pm

Classifying what a ‘good’ TCR looks like in terms of affinity, cross-reactivity and safety Screening and removing non-specific TCRs to guarantee tumor specificity Advancing technology to increase efficiency of discoveryRead more

day: Conference Day Two